HER2-NEGATIVE BREAST CANCER
Clinical trials for HER2-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a device help control advanced breast cancer?
Disease control Not yet recruitingThis study tests a device called TheraBionic P1 in 82 people with advanced or metastatic HR-positive, HER2-negative breast cancer who have already tried standard hormone therapies. The goal is to see if the device can slow cancer growth and improve survival. Participants will use…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Heat and immune combo takes on hard-to-treat breast cancer liver tumors
Disease control Not yet recruitingThis study tests whether combining a special heat treatment (multi-mode thermal therapy) with immunotherapy can help control HER2-negative breast cancer that has spread to the liver. About 30 women who have already tried at least one other treatment will receive this combination.…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Blood test may spare some breast cancer patients from chemotherapy
Disease control Not yet recruitingThis study tests a personalized approach for women with hormone receptor-positive, HER2-negative early breast cancer. Doctors use a blood test (ctDNA) to see if the cancer responds to a combination of targeted pills (CDK4/6 inhibitors) and hormone therapy before surgery. If the b…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Can better conversations improve breast cancer care?
Knowledge-focused Not yet recruitingThis study looks at whether training oncologists in shared decision-making and giving patients educational booklets and videos can improve how treatment choices are made for HER2-negative metastatic breast cancer. About 120 patients starting their first treatment will join, and t…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Federico II University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC